High Tower Advisors, LLC Royalty Pharma PLC Transaction History
High Tower Advisors, LLC
- $61.2 Billion
- Q1 2024
A detailed history of High Tower Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, High Tower Advisors, LLC holds 224,424 shares of RPRX stock, worth $6.32 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
224,424
Previous 175,396
27.95%
Holding current value
$6.32 Million
Previous $4.93 Million
38.35%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding RPRX
# of Institutions
394Shares Held
278MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.24 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$597 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$469 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$323 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...